Allergan, Inc. News Headlines

AGN 
$170.9
*  
0.75
0.44%
Get AGN Alerts
*Delayed - data as of Jul. 29, 2014  -  Find a broker to begin trading AGN now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Roche's Avastin Receives Positive Opinion from CHMP - Analyst Blog
6/30/2014 5:05:00 PM - Zacks.com

AbbVie's Oncology Candidate Progresses - Analyst Blog
6/30/2014 4:45:00 PM - Zacks.com

Bayer Drugs Get Positive CHMP Recommendation - Analyst Blog
6/30/2014 4:20:00 PM - Zacks.com

Allergan updates investors this morning on three pipeline programs
6/30/2014 10:09:00 AM - Seeking Alpha

Allergan Gets FDA Approval For Ozurdex, Announces R&D Pipeline Update
6/30/2014 9:09:00 AM - RTT News

Allergan Investor Conference Call At 10:30 AM ET
6/30/2014 8:36:00 AM - RTT News

Sector Update: Healthcare Lower; Allergan Defies Sector Hitting Record High on Deal With Pershing Square
6/27/2014 4:09:18 PM - MT Newswires

Sector Update: Healthcare
6/27/2014 4:01:22 PM - MT Newswires

Auxilium and QLT to Merge on Tax Saving Attractions - Analyst Blog
6/27/2014 12:10:00 PM - Zacks.com

McKesson Reiterates FY15 Earnings Guidance - Analyst Blog
6/26/2014 6:00:00 PM - Zacks.com

Glaxo's Promacta in Phase III for MDS - Analyst Blog
6/26/2014 2:30:00 PM - Zacks.com

Shire Snubs AbbVie Offer Again, Favorable Ruling for Vyvanse - Analyst Blog
6/26/2014 2:25:00 PM - Zacks.com

Sector Update: Healthcare; Cipher Pharmaceuticals Names New CEO, Valeant Bid For Allergan May Get Boost As Paulson & Co Buys Stake in Botox Maker
6/26/2014 1:04:14 PM - MT Newswires

AstraZeneca's Olaparib Fails to Impress FDA Panel - Analyst Blog
6/26/2014 11:10:00 AM - Zacks.com

Bristol-Myers Up on Nivolumab News - Analyst Blog
6/26/2014 10:45:00 AM - Zacks.com

Bayer Inks Hemophilia Deal with Dimension Therapeutics - Analyst Blog
6/25/2014 4:45:00 PM - Zacks.com

Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog
6/25/2014 10:45:00 AM - Zacks.com

Valeant Submits Preliminary Proxy Statement For Special Meeting Of Shareholders
6/25/2014 8:15:00 AM - RTT News

Forest Laboratories Reports Positive Data on Viibryd - Analyst Blog
6/24/2014 6:20:00 PM - Zacks.com

AbbVie Raises Outlook amidst Shire Takeover Attempts - Analyst Blog
6/24/2014 4:40:00 PM - Zacks.com

Abbott Labs to Buy Russia-Based Veropharm - Analyst Blog
6/24/2014 4:15:00 PM - Zacks.com

Allergan Rejects Valeant's Deal - Analyst Blog
6/24/2014 3:58:00 PM - Zacks.com

Clovis Oncology Initiates Study on CO-1686 - Analyst Blog
6/24/2014 11:40:00 AM - Zacks.com

ASPX Awaits Results, BZYR Creating Buzz, CGIX Opens Wallet, GNCA Hits A High
6/24/2014 12:49:00 AM - RTT News

Shire Rejects AbbVie's Offer, Shares Up - Analyst Blog
6/23/2014 5:31:00 PM - Zacks.com